MedMen Revenue and Competitors
Estimated Revenue & Valuation
- MedMen's estimated annual revenue is currently $193.7M per year.
- MedMen received $250.0M in venture funding in March 2019.
- MedMen's estimated revenue per employee is $342,900
- MedMen's total funding is $499M.
- MedMen's current valuation is $1.5B. (Mar 2019)
Employee Data
- MedMen has 565 Employees.
- MedMen grew their employee count by -2% last year.
MedMen's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Head Retail | Reveal Email/Phone |
3 | SVP, Technology Operations | Reveal Email/Phone |
4 | VP Equity Comp, Investor Relations & FP&A | Reveal Email/Phone |
5 | VP Field Operations | Reveal Email/Phone |
6 | Store Director | Reveal Email/Phone |
7 | Assistant Store Director Operations | Reveal Email/Phone |
8 | Assistant Store Director | Reveal Email/Phone |
9 | National Director Compliance and Security | Reveal Email/Phone |
10 | Director Accounting and Financial Reporting | Reveal Email/Phone |
MedMen Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $300M | 2480 | 3% | $560.5M | N/A |
#2 | $22.7M | 101 | 35% | $60.7M | N/A |
What Is MedMen?
MedMen Enterprises is the United States' preeminent cannabis company with multiple assets and operations in California, Nevada and New York. Combined, these key strategic states account for nearly half of North America's addressable legal market. MedMen owns and operates licensed cannabis facilities in cultivation, manufacturing and retail, and is the most recognized cannabis brand in the world today. MedMen brings class leading operational expertise and unprecedented investment to the fast changing and fast-growing cannabis industry as it moves from its gray market legacy to a fully regulated, legitimate and commercially viable market. Based in Los Angeles, MedMen employs nearly 800 workers across the U.S. It was founded in 2010 by Adam Bierman and Andrew Modlin, two visionary entrepreneurs who saw not just a tremendous business opportunity in the growing legalization of marijuana, but a chance to re-define our society's relationship with cannabis. The federal prohibition has had a disastrous impact, overpopulating our prisons and enriching violent drug cartels while keeping a relatively benign substance with proven benefits out of the reach of law abiding citizens. MedMen supports sensible, clear and just drug laws that strengthen communities and create economic opportunities. The company is the single largest financial supporter of progressive marijuana laws at the local, state and federal levels, giving directly to pro-legalization groups, industry organizations and political candidates. For more information, visit http://www.medmen.com
keywords:N/A$499M
Total Funding
565
Number of Employees
$193.7M
Revenue (est)
-2%
Employee Growth %
$1.5B
Valuation
N/A
Accelerator
MedMen News
Tilray also partially acquired MedMen, which has strong penetration in the U.S. cannabis retail market. According to CEO Irwin Simon,...
MedMen is an MSO with incredible value on the public markets. · Retail operations have class and cash flow. · Earnings will sustain Medmen moving...
One of MedMen Enterprises' 31 cannabis stores; the company is looking to expand in Massachusetts, Illinois, Arizona and California.
MedMen Announces Backstopped US$100M Equity Investment Led by Serruya Private Equity to Fund Expansion and Transform Balance Sheet LOS ANGELES - August 17, 2021 -- (BUSINESS WIRE) - MedMen Enterprises Inc. ('MedMen' or the 'Company') (CSE: MMEN) (OTCQX: MMNFF), a premier U.S. cannabis retaile ...
MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF), a premier U.S. cannabis retailer, today announced that investors, led by Serruya Private Equity ("SPE"), are purchasing US$100 million of units ("Units") of Medmen at a purchase price of US$0.24 (C$0.32) per Unit (th ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $147M | 582 | 58% | N/A |
#2 | $167M | 586 | 19% | N/A |
#3 | $104.7M | 588 | 28% | $450M |
#4 | $186.3M | 596 | 28% | N/A |
#5 | $222.9M | 650 | 1% | $85.5M |
MedMen Funding
Date | Amount | Round | Lead Investors | Reference |
---|---|---|---|---|
2016-04-20 | $15.0M | Undisclosed | Cap-Meridian Ventures | Article |
2017-01-18 | $30.0M | Undisclosed | Wicklow Capital | Article |
2017-06-14 | $60.0M | Undisclosed | Multiple | Article |
2018-10-02 | $73.7M | Undisclosed | Article | |
2018-10-05 | $100.0M | Undisclosed | Article | |
2019-03-25 | $250.0M | Undisclosed | Gotham Green Partners | Article |